Track topics on Twitter Track topics that are important to you
SummaryShanxi Zhendong Pharmaceutical Co Ltd Zhendong Group is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, respiratory drugs; antibiotics, antitumor drugs, vitamins, Chinese medicines, calcium preparations, active ...
SummaryLexicon Pharmaceuticals Inc Lexicon is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinicalstage drug program sotagliflozin LX4211 for type 1 and type 2 diabetes and its approved product Xermelo telotristat ethyl ...
SummarySihuan Pharmaceutical Holdings Group Ltd Sihuan Pharmaceutical is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardiocerebral vascular system, central nervous system, metabolism, oncology and antiinfectives. Its cardiocerebral vascular drug products comprise aoliankang, yeduojia, yuanzhijiu, oudi...
SummaryVerrica Pharmaceuticals Inc Verrica is a clinicalstage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company's lead product candidate, VP102, is in two phase 3 clinical trials for the treatment of molluscum contagiosum, a high contagious and primarily pediatric viral skin disease; and in a Phase 2 clinical trial ...
Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...